-
AstraZeneca will begin discussions this week with the FDA about modifying the design of its experimental COVID-19 vaccine trial to add a likely more effective dosage regime, as reported This is Money.
-
"In terms of how quickly, we will try and do that as quickly as possible," remarked Mene Pangalos, executive vice president of biopharmaceuticals R&D, adding it would be a "matter of weeks."
-
Pangalos said a regimen that includes a half dose being administered followed by a full dose one month later was better tolerated than using two full doses.
To read more NewsPoints articles, click here.
